Related Experiment Video
Updated: Oct 6, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
COVID-19 associated vasculitis: A systematic review of case reports and case series
Kalai Wong1, Mir Umer Farooq Alam Shah2, Maman Khurshid2
1UNC Eshelman School of Pharmacy, USA.
Insights
COVID-19 can cause vasculitis, a rare complication. This review of 9 cases found common skin rashes and successful treatment with heparin, corticosteroids, or IV immunoglobulin in most patients.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- COVID-19, a novel coronavirus infection, has been associated with various complications.
- Vasculitis, inflammation of blood vessels, is an emerging complication of COVID-19.
- Understanding the link between COVID-19 and vasculitis is crucial for patient management.
Purpose of the Study:
- To systematically review the existing literature on vasculitis associated with COVID-19.
- To analyze the clinical presentation, management, and outcomes of patients with COVID-19-related vasculitis.
Main Methods:
- A systematic literature search was conducted on Google Scholar and PubMed.
- Studies published from December 1, 2019, to October 11, 2021, were included.
- Data from 8 studies (7 case reports, 1 case series) involving 9 patients were analyzed.
Main Results:
- Nine cases of vasculitis secondary to COVID-19 were identified, with a mean age of 29.17 years (range: 6 months to 83 years).
- The male to female ratio was 4:5. Common presentations included maculopapular, violaceous, papular, and erythematous rashes.
- Treatments included heparin, corticosteroids (methylprednisolone), and intravenous immunoglobulin. Eight out of nine patients showed significant clinical improvement; one patient died.
Conclusions:
- Vasculitis is a potential complication of COVID-19, presenting with diverse skin manifestations.
- Prompt diagnosis and management, often involving immunosuppressive therapies, can lead to favorable outcomes.
- Further research is needed to elucidate the pathophysiology and long-term implications of COVID-19-associated vasculitis.
Abstract:
Vasculitis is one of the complications of COVID-19. We conducted a systematic review analysing the association of COVID-19 with vasculitis. We searched Google Scholar and PubMed from December 1, 2019, to October 11, 2021. The review included 8 studies (7 case reports and 1 case series) reporting 9 cases of vasculitis secondary to COVID-19. The mean age was 29.17 ± 28.2 years, ranging from 6 months to 83 years. The male to female ratio was 4:5. Maculopapular, violaceous, papular and erythematous rash were common. Heparin(n = 2), corticosteroids (n = 6) (methylprednisolone) and intravenous immunoglobulin (n = 4) were prescribed in these patients. Significant clinical improvement was observed in 8 out of 9 patients. One person died during treatment. Our study discusses vasculitis as one of the complications of COVID-19. Furthermore, the pathophysiology, clinical presentation, and management of COVID-19 associated vasculitis is discussed.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Nephrotic Syndrome II : Assessment and Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies

